Thrive Capital Management, LLC Edwards Lifesciences Corp Transaction History

Thrive Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 09, 2022	SELL	$106.37 - $130.68 $540,572 - $664,115	-5,082 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $36,635 - $43,699	-356 Reduced 6.55%	5,082 $575,000
Q2 2021 Aug 06, 2021	BUY	$83.84 - $104.76 $169,105 - $211,300	2,017 Added 58.96%	5,438 $563,000
Q1 2021 May 10, 2021	BUY	$78.68 - $90.67 $269,164 - $310,182	3,421 New	3,421 $286,000

1,330

457M

2.76M

2.09M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Thrive Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Thrive Capital Management, LLC with notifications on news.